Form D · Other Health Care
Accolade, Inc.
Plymouth Meeting, PA · CIK 0001481646
Offering snapshot reported Oct 15, 2021 · SEC filing
- Reported sold
- $11.3M Offering amount: $12.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 30, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 15, 2021 | Initial | $11,250,000 | No comparison | 1 | SEC filing |
| Jun 21, 2021 | Initial | $325,275,354 | No comparison | Not reported | SEC filing |
| Mar 12, 2021 | Initial | $129,998,958 | No comparison | 43 | SEC filing |
| Oct 16, 2019 | Initial | $19,999,996 | No comparison | 1 | SEC filing |
| Mar 30, 2018 | Initial | $27,185,748 | No comparison | 17 | SEC filing |
| Aug 9, 2016 | Initial | $55,000,000 | No comparison | 4 | SEC filing |
| Dec 7, 2015 | Amendment | $38,600,001 | $16,100,001vs Jul 17, 2015 | 5 | SEC filing |
| Jul 17, 2015 | Initial | $22,500,000 | No comparison | 2 | SEC filing |
| May 6, 2014 | Initial | $2,800,000 | No comparison | 1 | SEC filing |
| Dec 23, 2013 | Initial | $30,000,000 | No comparison | 17 | SEC filing |
| Jun 29, 2010 | Initial | $16,944,444 | No comparison | 17 | SEC filing |
| Jan 21, 2010 | Initial | $4,000,000 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-417151
Source: Form D, filed Oct 15, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steve Barnes | Executive |
| Stephen Barnes | Executive |
| Jeffrey Brodsky | Director |
| Jeff Brodsky | Director |
| Edgar, Jr. Bronfman | Director |
| Edgar Bronfman, Jr. | Director |
| Sheila Burke | Director |
| Robert Cavanaugh | Executive |
| J Michael Cline | Director |
| J. Michael Cline | Director |
| Debbie Cohen | Executive |
| Richard Eskew | Executive |
| William Frist | Director |
| William Frist, Sr. | Director |
| Michael Hilton | Executive |
| Mike Hilton | Executive |
| Ivor Horn | Executive |
| Jeff Jordan | Director |
| Cindy Kent | Director |
| Peter Klein | Director |
| Dawn Lepore | Director |
| Mark Mactas | Director |
| James C. Madden | Director |
| James C. Madden, V | Director |
| Elizabeth Nabel | Director |
| Elizabeth Napolitano | Executive |
| Thomas J. Neff | Director |
| John Rollins | Executive |
| John W. Rowe | Director |
| Rajeev Singh | Director, Executive |
| Jeff Smith | Executive |
| Thomas K Spann | Director, Executive |
| Arthur H. Spiegel | Director |
| Dave Swift | Executive |
| Patricia Wadors | Director |
| Michael T. Yang | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
660 W. Germantown Pike Suite 500
Plymouth Meeting, PA, 19462
Plymouth Meeting, PA, 19462